Glucose -6 -phosphate dehydrogenase ( G -6 -PD ) deficiency is a common condition with a worldwide distribution that has the potential for causing severe hyperbilirubinemia with bilirubin encephalopathy. Hemolysis resulting from identifiable triggers may be the cause of the jaundice in some cases, but in many, jaundice continues to occur despite avoidance of contact with known hemolytic triggers. In some G -6 -PD -deficient population groups, carboxyhemoglobin studies have indicated exaggerated hemolysis; but in others, increased hemolysis has not correlated with serum total bilirubin values.
As hyperbilirubinemia results from an imbalance between bilirubin production and bilirubin elimination, diminished bilirubin conjugation was suspected to contribute to the pathogenesis of hyperbilirubinemia. Serum -conjugated bilirubin fractions, reflecting intrahepatocytic bilirubin conjugation, were low in G -6 -PD -deficient neonates who developed hyperbilirubinemia. This conjugated bilirubin profile was similar to that seen in adults with Gilbert's Syndrome, a condition associated with promoter polymorphism for the gene encoding the bilirubin -conjugating enzyme, UGT glucuronosyltransferase 1A1 ( UGT ). Whereas G -6 -PD deficiency or Gilbert's Syndrome, alone, did not predispose to hyperbilirubinemia, G -6 -PD -deficient neonates who also were heterozygotes or homozygotes for the variant UGT gene promoter did have significantly increased incidences of hyperbilirubinemia. Additional conditions which predispose to neonatal jaundice in the presence of Gilbert's Syndrome, include Coombs' negative ABO blood group heterospecificity, hereditary spherocytosis, and prolonged breastfeeding.
Gilbert's Syndrome and G -6 -PD deficiency are both common, inherited conditions. Individually, and in the absence of additional genetic or environmental factors, both are benign, and should result in minimal health disturbance or interference with the quality of life of affected
but Gilbert's Syndrome is associated with a polymorphism in the form of a missense mutation in the coding area of the UGT 1A1 gene. A G!A transition at nucleotide 211 causes arginine to replace glycine at position 71 of the corresponding protein product (G71R mutation).
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GLUCOSE-6-PHOSPHATE DEHYDROGENASE (G-6-PD) DEFICIENCY G-6-PD deficiency is one of the most common enzyme deficiencies known, affecting hundreds of millions of people. 7 Although originally it was distributed in Africa, southern Europe, the Middle East, and Asia, migration of population groups and ease of travel in modern times have resulted in a virtually worldwide distribution. The enzyme G-6-PD plays a major role in the protection of cells against oxidative damage by participating in the role played by reduced glutathione in this process. In order for glutathione to be effective as an antioxidant, it must be maintained in its reduced form, and be continually regenerated from its oxidized form. This regeneration utilizes hydrogen ions obtained from the reduced form of nicotinamide-adenine dinucleotide phosphate (NADPH), which is formed from NADP, the reaction being catalyzed by G-6-PD in the first step of the hexose monophosphate pathway. In situations of G-6-PD deficiency, NADPH will not be available for the regeneration of reduced glutathione and the oxidative process will not be counteracted. The red blood cell is at especially high risk for this oxidative damage, as, unlike other cells, the hexose monophosphate pathway is the only source of NADPH. Oxidative damage may be exacerbated by the high concentrations of oxygen normally present in these cells. Damage to the cell membrane and hemolysis will be the result.
In the absence of extraneous triggers of hemolysis or additional icterogenic factors, G-6-PD-deficient individuals may lead perfectly normal lives, with no untoward effects, other than a mild hemolytic anemia. However, contact with both identified and unknown hemolytic triggers, including, e.g., metabolites of the fava bean (favism), naphthalene, and certain drugs, may result in acute, life-threatening hemolysis.
G-6-PD DEFICIENCY AND NEONATAL JAUNDICE
A common complication of G-6-PD deficiency is that of severe neonatal hyperbilirubinemia with the potential of bilirubin encephalopathy or kernicterus. 8 -10 Because of the association of G-6-PD deficiency with severe, acute hemolysis, this hyperbilirubinemia has traditionally been related to as hemolytic in origin. In many cases, this may indeed be the case, and substances such as triple dye, menthol, and Chinese remedies, each of which has been applied to the umbilicus for antisepsis, have been implicated as triggers of hemolysis. Additional triggers may include metabolites of fava, transmitted via breast milk of mothers who had ingested the bean, and henna, which is frequently applied to the newborn's skin in some Middle Eastern societies. G-6-PD-deficient neonates with obvious, acute hemolysis, in whom no trigger can be identified, are sometimes encountered. 11 Possible agents in such circumstances may include viral or bacterial infections, or newly introduced chemical cleaning substances.
However, strict avoidance of known triggers of hemolysis in G-6-PD-deficient individuals, while preventing favism-like hemolysis, does not prevent G-6-PD-deficient neonates from having a significantly higher incidence of hyperbilirubinemia than G-6-PDnormal control neonates. Furthermore, hyperbilirubinemia in these infants is infrequently accompanied by decreasing hemoglobin (Hb) or hematocrit (Hct) values, or by increased reticulocyte counts. 12 As serum bilirubin values, at any point in time, represent a balance between bilirubin production and bilirubin elimination, primarily conjugation, it therefore seemed logical to imply diminished hepatic bilirubin conjugation as the primary site of pathology in this form of G-6-PD deficiency-associated neonatal hyperbilirubinemia. The following discussion reviews a series of studies in an effort to elucidate both the part played by increased hemolysis and diminished bilirubin conjugation in the pathogenesis of the hyperbilirubinemia.
ROLE OF HEMOLYSIS IN G-6-PD DEFICIENCY ASSOCIATED NEONATAL HYPERBILIRUBINEMIA
Hematological indices associated with hemolysis in adults are not always useful in the identification of hemolysis in newborns because of overlap in values between hemolytic and non-hemolytic states. Studies of hematological parameters in G-6-PD-deficient neonates have not consistently shown evidence of acute hemolysis. On one hand, G-6-PD-deficient Nigerian neonates have shown a clear relationship between lower Hct values and the development of neonatal jaundice; the values of those who developed kernicterus are at the lowest end of the spectrum (29.5% [27% to 50%]; median [interquartile range] ). 13 On the other hand, in Sardinian newborns, Hb and Hct values have not been lower in those who developed hyperbilirubinemia than in those who were only minimally jaundiced.
14 In Sephardic-Jewish infants studied in Israel on the first day after birth, we detected no significant differences between G-6-PD-deficient neonates and controls, or between those who developed hyperbilirubinemia and those with only moderate jaundice. 12 In a subsequent study, in which infants of the same population group were studied on the third day after birth, although the mean total Hb value was significantly lower in the G-6-PD-deficient group compared with controls (17.6±2.7 vs 18.8±2.4 g/dl, p=0.001), this difference clearly is not as extreme as documented in the severest of the cases in the Nigerian study. 15 In one Greek study, Hb values were paradoxically higher in neonates whose STB values were sufficiently high to warrant exchange transfusion, compared with those with lower STB values, suggesting factors other than acute hemolysis in the pathophysiology of their hyperbilirubinemia.
The most accurate method of assessing hemolysis in the neonate is by assessing the endogenous production of carbon monoxide (CO). 17 The principle behind this method is that for each molecule of bilirubin produced from heme by the enzyme heme oxygenase, one molecule of CO is released. Necheles et al. 18 reported a higher value for carboxyhemoglobin (COHb) in hyperbilirubinemic G-6-PD-deficient Greek neonates ( >1%), compared with non-hyperbilirubinemic G-6-PD-normal controls ( <1%). Slusher et al. 13 found significantly higher COHb values in G-6-PD-deficient Nigerian neonates than in control neonates (2.3% [1.3% to 4.2%] vs 1.2% [1.0% to 1.7%] ); these values correlated with the severity of the jaundice and were highest in neonates who developed kernicterus (3.72% [2.13% to 5.93%] ).
The clear role of hemolysis in the pathogenesis of hyperbilirubinemia in the Nigerian population contrasts with that in Israeli Sephardic-Jewish neonates: COHbc values, corrected for inspired CO (COHbc), were significantly higher in the latter G-6-PD-deficient infant population compared with controls (0.75±0.17% vs 0.62±0.19%, p<0.001). However, there was no correlation between COHbc values and STB values in the G-6-PD-deficient group, but these values did correlate among control infants. Furthermore, COHbc values in hyperbilirubinemic (STB256 mol/l [15.0 mg/dl] ) G-6-PDdeficient neonates were not significantly higher than values in hyperbilirubinemic control neonates. Of interest, COHbc values in non-hyperbilirubinemic G-6-PD-deficient neonates were significantly higher than non-hyperbilirubinemic control neonates. 15 Therefore, although there was clearly increased hemolysis in the G-6-PD-deficient neonates, it was not limited to those who developed hyperbilirubinemia. Hemolysis appears to be the hallmark of the G-6-PD-deficient neonatal RBC, and is probably the result of interaction between naturally occurring oxidants and the diminished antioxidant responses of the enzyme-deficient cells. However, it cannot be implicated as a cardinal component of the pathogenesis of these infants' bilirubinemia.
ROLE OF BILIRUBIN CONJUGATION IN THE PATHOPHYSIOLOGY OF JAUNDICE
Because of the inaccessibility of neonatal liver tissue, assessment of bilirubin conjugation in the pathogenesis of G-6-PD deficiency-associated neonatal hyperbilirubinemia has necessarily been difficult, and has lagged behind advances in assessment of the rate of hemolysis. It is now appreciated that small amounts of conjugated bilirubin reflux from the hepatocyte into the serum, and accurate determination of serum-conjugated bilirubin fractions provide a reflection of intrahepatocytic bilirubin conjugation. Using a sensitive reversephase, high-performance liquid chromatographic system, specific for the measurement of unconjugated and conjugated serum bilirubin fractions, Kaplan et al. 19 compared hyperbilirubinemic (STB256 mol/l [15.0 mg/dl] ) G-6-PD-deficient neonates with hyperbilirubinemic controls. They found a decreased diconjugated fraction in the former (0.06 mol/l [0.00 to 1.84 mol/l], median [range], vs 0.21 mol/l [0.00 to 1.02 mol/l], p=0.006). This pattern of conjugated serum bilirubin fractions seen in the G-6-PD-deficient newborns was similar to that reported in adults with Gilbert's Syndrome, and was thought to represent a bilirubin-conjugating capacity that was even more immature than that found in normal neonates.
In a second study, the same authors sampled G-6-PD-deficient neonates in the first days of life while the STB values were between 171 (10.0 mg/dl) and 254 mol/l (14.9 mg/dl). Babies were subsequently separated, naturally, into those who became hyperbilirubinemic, and those who remained with only moderately elevated STB levels. Despite similar total and unconjugated bilirubin values at the time of sampling, serum total conjugated, monoconjugated, and diconjugated bilirubin fractions were all significantly lower in those babies who developed hyperbilirubinemia than in those who did not. 20 These two studies showed diminished serum conjugated bilirubin fractions in G-6-PD-deficient neonates who developed hyperbilirubinemia, signifying that bilirubin conjugation was diminished in these neonates and that the decreased bilirubin conjugation was a crucial factor in the development of their hyperbilirubinemia.
ROLE OF GILBERT'S SYNDROME IN G-6-PD DEFICIENCY-ASSOCIATED NEONATAL HYPERBILIRUBINEMIA
The similarity of the serum-conjugated bilirubin fraction profile in the G-6-PD-deficient neonates to that of adults with Gilbert's Syndrome suggested a possible relationship between the UGT gene with the variant promoter and the development of hyperbilirubinemia. However, neither Bancroft et al. 21 nor Kaplan et al. 22 found a , 22 with permission from Proc Natl Acad Sci USA ).
Kaplan
Neonatal Hyperbilirubinemia Pathogenesis relationship between presence of the variant UGT promoter, in the absence of additional icterogenic factors, and development of hyperbilirubinemia. However, in the G-6-PD-deficient neonatal population, the incidence of hyperbilirubinemia increased significantly from 9.7% in those homozygous for the normal UGT promoter, which was almost identical to the incidence in the G-6-PD-normal population, to 31.6% in those heterozygous for the variant UGT promoter, to 50% of those homozygous for the variant promoter gene (Figure 1) . Neither of these genetic factors alone was associated with a significant effect on the incidence of hyperbilirubinemia. However, combination of the two genes did significantly increase the incidence of hyperbilirubinemia. Thus, presence of G-6-PD deficiency appeared to be crucial for the gene for Gilbert's Syndrome to have an icterogenic effect. Furthermore, as none of these factors alone was icterogenic, the effect of their combination could not be attributed to a simple additive effect, but rather to a gene interaction. This interaction has been exemplified as a paradigm of benign genetic polymorphisms combining in the causation of disease.
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ADDITIONAL INTERACTIONS OF GILBERT'S SYNDROME IN THE PATHOGENESIS OF NEONATAL JAUNDICE
Several other conditions have been described in which Gilbert's Syndrome has been shown to exacerbate the development of neonatal hyperbilirubinemia. Iolascon et al. 23 showed that Gilbert's Syndrome exacerbates neonatal jaundice in hereditary spherocytosis. Whereas 63% of Italian neonates with this condition who were homozygous for the normal UGT gene promoter, and 56% of heterozygotes for the variant promoter developed hyperbilirubinemia requiring phototherapy, 97% of those homozygous for the variant gene promoter became hyperbilirubinemic. Studying direct Coombs' negative ABO heterospecific neonates (mother blood group O, baby group A or B), Kaplan et al. 24 found a significantly increased incidence of hyperbilirubinemia only among those who were also homozygous for the variant UGT gene promoter (Figure 2) . Monaghan et al. 25 found a significantly increased incidence of homozygosity for the variant UGT gene promoter among Scottish breastfeeding newborns with prolonged neonatal jaundice (31%), compared with 6% of those with acute jaundice, and 12% of the adults in that population.
CONCLUSION
Neither G-6-PD deficiency nor Gilbert's Syndrome, in the absence of additional environmental or genetic influences, should interfere with day-to-day living, and both should be benign. G-6-PD deficiency, in the presence of oxidizing agents such as fava bean metabolites, may result in severe, life-threatening hemolysis, and, in the presence of Gilbert's Syndrome, may result in a significantly increased incidence of neonatal hyperbilirubinemia. Gilbert's Syndrome, on the other hand, in the absence of additional icterogenic factors did not exacerbate the incidence of hyperbilirubinemia, but in the presence of G-6-PD deficiency, ABO blood group heterospecificity, or hereditary spherocytosis, it was a major factor in the pathogenesis of hyperbilirubinemia. These observations support the concept of multifactorial etiology and pathogenesis of neonatal hyperbilirubinemia, of which genetic interactions may play an important part. , 24 with permission from Lancet ).
